Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.66% |
| 2 | Healthcare | 3.16% |
| 3 | Industrials | 2.01% |
| 4 | Financials | 1.98% |
| 5 | Consumer Discretionary | 1.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9626
PUT
iShares US Oil Equipment & Services ETF
IEZ
$359M
| $193K | ﹤0.01% |
17,200
+2,000
| +13% | +$18.6K |
|
9627
LiveOne
LVO
$57.2M
| $193K | ﹤0.01% |
5,898
+3,403
| +136% | +$82.9K |
|
9628
SandRidge Energy
SD
$487M
| $193K | ﹤0.01% |
+62,270
| New | +$153K |
|
|
OSG
9629
PUT
Octave Specialty Group
OSG
$256M
| $192K | ﹤0.01% |
+12,500
| New | +$184K |
|
9630
PUT
Golub Capital BDC
GBDC
$3.34B
| $192K | ﹤0.01% |
+13,600
| New | +$186K |
|
|
PDM
9631
PUT
Piedmont Realty Trust
PDM
$1.21B
| $192K | ﹤0.01% |
+11,800
| New | +$174K |
|
9632
CALL
Pebblebrook Hotel Trust
PEB
$2.15B
| $192K | ﹤0.01% |
+10,200
| New | +$165K |
|
9633
Precigen
PGEN
$2.46B
| $192K | ﹤0.01% |
18,779
-290,423
| -94% | -$1.88M |
|
9634
ProShares Trust UltraShort Lehman 7-10 Year Treasury
PST
$10.5M
| $192K | ﹤0.01% |
12,428
+804
| +7% | +$12.4K |
|
|
AVEO
9635
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $192K | ﹤0.01% |
33,260
+5,460
| +20% | +$31.3K |
|
|
YDKG
9636
CALL
Yueda Digital Holding
YDKG
$5.97M
| $191K | ﹤0.01% |
+219
| New | +$102K |
|
9637
iShares MSCI Poland ETF
EPOL
$747M
| $191K | ﹤0.01% |
+10,055
| New | +$174K |
|
9638
PUT
Vera Bradley
VRA
$99.2M
| $191K | ﹤0.01% |
24,000
+5,500
| +30% | +$41.6K |
|
9639
CALL
Cato Corp
CATO
$68.5M
| $190K | ﹤0.01% |
19,800
+1,800
| +10% | +$14.2K |
|
|
9640
Cato Corp
CATO
$68.5M
| $190K | ﹤0.01% |
19,758
+5,150
| +35% | +$40.6K |
|
9641
CALL
Precision BioSciences
DTIL
$193M
| $190K | ﹤0.01% |
760
-140
| -16% | -$34.3K |
|
9642
Mizuho Financial
MFG
$130B
| $190K | ﹤0.01% |
+74,335
| New | +$192K |
|
9643
PUT
Prospect Capital
PSEC
$1.09B
| $190K | ﹤0.01% |
35,200
-25,400
| -42% | -$134K |
|
|
EXPR
9644
CALL
DELISTED
Express, Inc.
EXPR
| $190K | ﹤0.01% |
10,435
+8,675
| +493% | +$164K |
|
|
SIOX
9645
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $190K | ﹤0.01% |
68,431
+5,987
| +10% | +$17.4K |
|
9646
America Movil
AMX
$72.1B
| $189K | ﹤0.01% |
13,028
+2,875
| +28% | +$39K |
|
|
DX
9647
CALL
Dynex Capital
DX
$3.19B
| $189K | ﹤0.01% |
10,600
-16,100
| -60% | -$275K |
|
|
SFT
9648
CALL
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
| $189K | ﹤0.01% |
2,280
+760
| +50% | +$70.4K |
|
9649
American Coastal Insurance
ACIC
$531M
| $188K | ﹤0.01% |
32,820
-12,691
| -28% | -$64.1K |
|
9650
AXT Inc
AXTI
$4.49B
| $188K | ﹤0.01% |
+19,646
| New | +$158K |
|
Similar funds
Citadel Advisors's Q4 2020 Portfolio in Review
As of Q4 2020, Citadel Advisors held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.7% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Citadel Advisors opened a new position in S&P Global worth $114M.
- Citadel Advisors's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Citadel Advisors fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Citadel Advisors's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Citadel Advisors opened 1,989 new positions and closed 1,130 in Q4 2020.
- Citadel Advisors's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.